Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-24 04:06:37 - browse：6817

FDA-Blood Sugar Monitor — The FDA has approved a device from Abbott that continuously monitors diabetics’ blood sugar levels without requiring backup finger prick tests. Abbott Laboratories via AP

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn’t need backup finger prick tests.

Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

The pain of finger sticks and the cost of testing supplies discourage many people from keeping close tabs on their blood sugar, which is needed to manage insulin use and adjust what they eat.

Abbott’s new FreeStyle Libre Flash Glucose Monitoring System, approved Wednesday by the Food and Drug Administration, uses a small sensor attached to the upper arm. Patients wave a reader device over it to see the current blood sugar level and changes over the past eight hours.

Most of the 30 million Americans with diabetes use standard glucose meters, which require multiple finger pricks each day and only show current sugar level. More-accurate continuous glucose monitoring devices are used by about 345,000 Americans.

Newsletters

Sign up for Morning Rounds

Your daily dose of news in health and medicine.

Please enter a valid email address. Privacy Policy

But most don’t do the finger pricks to calibrate them and may get inaccurate readings, said Dr. Timothy Bailey, who helped test FreeStyle Libre.

“We’re able to lower blood sugar safely” with this technology, said Bailey, director of the Advanced Metabolic Care and Research Institute in California. He receives consulting fees from various diabetes device makers.

Too-high blood sugar levels can damage organs and lead to heart attacks, strokes, blindness and amputations. Very low blood sugar can cause seizures, confusion and loss of consciousness.

Abbott’s device was approved for adults with type 1 or type 2 diabetes and should be available in pharmacies within months. The company, based near Chicago, did not disclose the price of the reader or the sensors.

Abbott’s system can’t be used with an insulin pump, a device worn against the skin that allows users to inject insulin as needed, but the company is planning improvements to eventually enable that.

Rival Medtronic this spring launched a device in which the insulin pump automatically responds to blood sugar changes recorded by the sensor and either withholds or injects insulin as needed.

— Linda A. Johnson

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： How to use technology to prevent future drug shortages

WSS

Methadone doses haven’t kept up in the age of fentanyl

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Maui's cultural, historic landmarks damaged in the devastating wildfires

UCLA team creates talking throat patch for voice disorders

Wikipedia

Wikipedia

Sign up for Morning Rounds

explore

Sports medicine is finally prioritizing gender equality

The best solution to the drug shortages problem

23andMe had bad news about my health. I wish a person had delivered it

Why depression after traumatic brain injury is distinct

Wildfire smoke exposes gaps in outdoor worker protections

Police still searching for prisoner who escaped from NYC hospital

Novavax promises a turnaround & Lilly roils the obesity market

Why failed clinical trials don’t always spell doom for a new drug

Apple is now the first public company to be valued at $3 trillion

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

hotspot

Anavex keeps shifting the goalposts in its clinical trials

Man killed during FBI raid in connection with threats against Biden, other officials

Change Healthcare outage fallout shows need for new oversight

WuXi out of biotech trade group, U.S. and China relations to blame

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

explore

focus

hotspot

explore